ArticleDrug design, development and therapy2015

Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.

Ling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.